Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
PURPOSE: We tested whether total prostate-specific antigen velocity (tPSAv) improves accuracy of a model using PSA level to predict long-term risk of prostate cancer diagnosis. METHODS: During 1974 to 1986 in a preventive medicine study in Sweden, 5,722 men aged
Бібліографічні деталі
Автори: |
Ulmert, D,
Serio, A,
O'Brien, M,
Becker, C,
Eastham, J,
Scardino, P,
Björk, T,
Berglund, G,
Vickers, A,
Lilja, H |
Формат: | Journal article
|
Мова: | English |
Опубліковано: |
2008
|